The set of Endoret® technology (prgf®) formulations represent a solution in terms of safety, efficacy and reproducibility that ophthalmologists demanded in the treatment of various ocular pathologies.
The fibrin-free plasma rich in growth factors formulation has been developed for daily use, is kept at ambient temperature and can be used anywhere and at any time.
Autologous fibrin formulations act as a scaffold in eye surgery, accelerating recovery, improving visual acuity, reducing pain and inflammation and reducing fibrosis. All this allows to improve eye surgery treatments such as:
Autologous PRGF eye drops are used in pathologies such as:
Using the different autologous fibrin formulations improves eye surgery treatments such as: